CD8A and COVID-19: Taken together, these results demonstrate that, like SARS-CoV-2-specific CD4+ T cells, an overall higher magnitude of CCCs/SARS-CoV-2 cross-reactive CD8+ T-cell responses were present in asymptomatic COVID-19 patients who never presented any COVID-19 symptoms, despite being infected.